UniProt ID | UCKL1_HUMAN | |
---|---|---|
UniProt AC | Q9NWZ5 | |
Protein Name | Uridine-cytidine kinase-like 1 | |
Gene Name | UCKL1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 548 | |
Subcellular Localization | Cytoplasm . Nucleus . EBNA3 induces isoform 1 translocation to the nucleus, whereas it does change isoform 3 location. | |
Protein Description | May contribute to UTP accumulation needed for blast transformation and proliferation.. | |
Protein Sequence | MAAPPARADADPSPTSPPTARDTPGRQAEKSETACEDRSNAESLDRLLPPVGTGRSPRKRTTSQCKSEPPLLRTSKRTIYTAGRPPWYNEHGTQSKEAFAIGLGGGSASGKTTVARMIIEALDVPWVVLLSMDSFYKVLTEQQQEQAAHNNFNFDHPDAFDFDLIISTLKKLKQGKSVKVPIYDFTTHSRKKDWKTLYGANVIIFEGIMAFADKTLLELLDMKIFVDTDSDIRLVRRLRRDISERGRDIEGVIKQYNKFVKPSFDQYIQPTMRLADIVVPRGSGNTVAIDLIVQHVHSQLEERELSVRAALASAHQCHPLPRTLSVLKSTPQVRGMHTIIRDKETSRDEFIFYSKRLMRLLIEHALSFLPFQDCVVQTPQGQDYAGKCYAGKQITGVSILRAGETMEPALRAVCKDVRIGTILIQTNQLTGEPELHYLRLPKDISDDHVILMDCTVSTGAAAMMAVRVLLDHDVPEDKIFLLSLLMAEMGVHSVAYAFPRVRIITTAVDKRVNDLFRIIPGIGNFGDRYFGTDAVPDGSDEEEVAYTG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
13 | Phosphorylation | ARADADPSPTSPPTA CCCCCCCCCCCCCCC | 41.16 | 30266825 | |
15 | Phosphorylation | ADADPSPTSPPTARD CCCCCCCCCCCCCCC | 59.19 | 30266825 | |
16 | Phosphorylation | DADPSPTSPPTARDT CCCCCCCCCCCCCCC | 32.06 | 29255136 | |
19 | Phosphorylation | PSPTSPPTARDTPGR CCCCCCCCCCCCCCC | 37.40 | 29255136 | |
23 | Phosphorylation | SPPTARDTPGRQAEK CCCCCCCCCCCCCCC | 23.30 | 20068231 | |
39 | Phosphorylation | ETACEDRSNAESLDR CCCCCCCCCHHHHHH | 53.35 | 21712546 | |
43 | Phosphorylation | EDRSNAESLDRLLPP CCCCCHHHHHHHCCC | 32.91 | 21712546 | |
53 | Phosphorylation | RLLPPVGTGRSPRKR HHCCCCCCCCCCCCC | 29.65 | 30266825 | |
56 | Phosphorylation | PPVGTGRSPRKRTTS CCCCCCCCCCCCCHH | 30.33 | 29255136 | |
61 | Phosphorylation | GRSPRKRTTSQCKSE CCCCCCCCHHHCCCC | 33.56 | 25106551 | |
62 | Phosphorylation | RSPRKRTTSQCKSEP CCCCCCCHHHCCCCC | 22.34 | 25106551 | |
63 | Phosphorylation | SPRKRTTSQCKSEPP CCCCCCHHHCCCCCC | 32.73 | 23927012 | |
66 | Ubiquitination | KRTTSQCKSEPPLLR CCCHHHCCCCCCCEE | 50.66 | - | |
67 | Phosphorylation | RTTSQCKSEPPLLRT CCHHHCCCCCCCEEC | 64.06 | 23927012 | |
74 | Phosphorylation | SEPPLLRTSKRTIYT CCCCCEECCCCEEEE | 38.27 | 26074081 | |
75 | Phosphorylation | EPPLLRTSKRTIYTA CCCCEECCCCEEEEC | 17.44 | 26074081 | |
78 | Phosphorylation | LLRTSKRTIYTAGRP CEECCCCEEEECCCC | 23.28 | 25404012 | |
80 | Phosphorylation | RTSKRTIYTAGRPPW ECCCCEEEECCCCCC | 7.02 | 25404012 | |
81 | Phosphorylation | TSKRTIYTAGRPPWY CCCCEEEECCCCCCC | 20.84 | 25404012 | |
88 | Phosphorylation | TAGRPPWYNEHGTQS ECCCCCCCCCCCCCC | 19.22 | 25404012 | |
93 | Phosphorylation | PWYNEHGTQSKEAFA CCCCCCCCCCCEEEE | 31.41 | 25404012 | |
95 | Phosphorylation | YNEHGTQSKEAFAIG CCCCCCCCCEEEEEE | 32.09 | 25404012 | |
107 | Phosphorylation | AIGLGGGSASGKTTV EEECCCCCCCCHHHH | 23.65 | 21082442 | |
111 | Ubiquitination | GGGSASGKTTVARMI CCCCCCCHHHHHHHH | 38.23 | - | |
179 | Acetylation | LKQGKSVKVPIYDFT HHCCCCEEEEEEECC | 49.76 | 25953088 | |
179 | Ubiquitination | LKQGKSVKVPIYDFT HHCCCCEEEEEEECC | 49.76 | - | |
196 | Phosphorylation | SRKKDWKTLYGANVI CCCCCHHHHHCCCEE | 22.43 | 30622161 | |
198 | Phosphorylation | KKDWKTLYGANVIIF CCCHHHHHCCCEEEE | 21.30 | 30622161 | |
215 | Phosphorylation | IMAFADKTLLELLDM HHHHCCHHHHHHCCC | 36.80 | - | |
228 | Phosphorylation | DMKIFVDTDSDIRLV CCEEEECCHHHHHHH | 31.91 | - | |
230 | Phosphorylation | KIFVDTDSDIRLVRR EEEECCHHHHHHHHH | 36.71 | - | |
254 | Ubiquitination | RDIEGVIKQYNKFVK CCHHHHHHHHHHHHC | 44.30 | - | |
261 | Ubiquitination | KQYNKFVKPSFDQYI HHHHHHHCCCHHHHC | 37.77 | 21906983 | |
261 (in isoform 1) | Ubiquitination | - | 37.77 | 21906983 | |
261 (in isoform 2) | Ubiquitination | - | 37.77 | 21906983 | |
261 (in isoform 3) | Ubiquitination | - | 37.77 | 21906983 | |
313 | Phosphorylation | SVRAALASAHQCHPL HHHHHHHHHHHCCCC | 27.43 | 28555341 | |
317 | S-nitrosylation | ALASAHQCHPLPRTL HHHHHHHCCCCCCHH | 2.27 | 22178444 | |
328 (in isoform 3) | Ubiquitination | - | 50.56 | 21906983 | |
328 | Ubiquitination | PRTLSVLKSTPQVRG CCHHHHHHCCCCCCC | 50.56 | 21906983 | |
328 (in isoform 1) | Ubiquitination | - | 50.56 | 21906983 | |
343 | Ubiquitination | MHTIIRDKETSRDEF CEEEECCCCCCHHHH | 53.71 | - | |
387 | Ubiquitination | QGQDYAGKCYAGKQI CCCCCCCCCCCCCEE | 18.85 | - | |
392 | Ubiquitination | AGKCYAGKQITGVSI CCCCCCCCEECEEEE | 30.29 | - | |
505 | Phosphorylation | FPRVRIITTAVDKRV CCCEEEEEHHHHHHH | 13.31 | 23403867 | |
506 | Phosphorylation | PRVRIITTAVDKRVN CCEEEEEHHHHHHHH | 17.80 | 23403867 | |
510 | Malonylation | IITTAVDKRVNDLFR EEEHHHHHHHHHHHH | 52.20 | 26320211 | |
510 | Ubiquitination | IITTAVDKRVNDLFR EEEHHHHHHHHHHHH | 52.20 | - | |
510 (in isoform 1) | Ubiquitination | - | 52.20 | 21906983 | |
510 | Acetylation | IITTAVDKRVNDLFR EEEHHHHHHHHHHHH | 52.20 | 23749302 | |
529 | Phosphorylation | IGNFGDRYFGTDAVP CCCCCCCCCCCCCCC | 15.88 | 30108239 | |
532 | Phosphorylation | FGDRYFGTDAVPDGS CCCCCCCCCCCCCCC | 15.75 | 30108239 | |
539 | Phosphorylation | TDAVPDGSDEEEVAY CCCCCCCCCHHHHCC | 49.59 | 12199906 | |
546 | Phosphorylation | SDEEEVAYTG----- CCHHHHCCCC----- | 19.71 | 30108239 | |
547 | Phosphorylation | DEEEVAYTG------ CHHHHCCCC------ | 27.03 | 30108239 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UCKL1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UCKL1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
BCS1_HUMAN | BCS1L | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16 AND SER-539, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-56, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16, AND MASSSPECTROMETRY. |